Skip to main content
VCbacked
Log inGet Started

MAIA Biotechnology

Chicago, United States

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.

$30.0M raised
Mar 2026
Post Ipo Equity
BiotechnologyHealth CareOncologyTherapeutics

Top Investors

National Institutes of HealthCheckmate CapitalKIZOO Technology CapitalMDL InvestmentsBenjamin Kong

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MAIA Biotechnology

How much funding has MAIA Biotechnology raised?
MAIA Biotechnology has raised $30.0M in total funding. The most recent round was Post Ipo Equity. The last funding was announced in March 2026.
Who are MAIA Biotechnology's investors?
MAIA Biotechnology's investors include National Institutes of Health, Checkmate Capital, KIZOO Technology Capital, MDL Investments, Benjamin Kong.
Where is MAIA Biotechnology headquartered?
MAIA Biotechnology is headquartered in Chicago, United States.
What does MAIA Biotechnology do?
MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.
What stage is MAIA Biotechnology at?
MAIA Biotechnology is at the Post Ipo Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"MAIA Biotechnology — Funding & Investors." VCBacked, March 2, 2026, https://www.vcbacked.co/company/maia-biotechnology. Accessed July 2, 2026.
APA
VCBacked. (2026). MAIA Biotechnology — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/maia-biotechnology
Wikipedia (cite web)
{{cite web |title=MAIA Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/maia-biotechnology |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K